Quantum-Si Incorporated - Class A is a pioneering life sciences company founded in 2013, based in Branford, Connecticut. It focuses on revolutionizing protein analysis through its innovative Next Generation Protein Sequencing (NGPS) technology. This technology, which includes the Platinum NGPS instrument, Platinum Analysis Software, and specialized reagent kits and semiconductor chips, aims to enhance protein identification, antibody characterization, and biomarker discovery, among other applications. Quantum-Si's advancements promise to open new frontiers in understanding proteins and their roles in health and disease.
Live Updates First earnings reaction4:30pm ETFirst reaction to QSIs earnings: 1. Product traction:Platinum Pro officially launched and shipped, but no units/revenue per customer disclosed. Adoption remains early-stage. 2. Burn rate update:Q1 net…
Joel South Quantum computing, which offers the promise of faster computational power than what’s currently available, has implications for artificial intelligence (AI) and other lucrative technology fields. It also holds the promise of potential…
One of Cathie Wood's Ark Invest funds bought over 800,000 shares of Quantum-Si on July 22.
One of Cathie Wood's Ark Invest funds bought over 280,000 shares of Quantum-Si on July 13.
One of Cathie Wood's Ark Invest funds bought over 350,000 shares of Quantum-Si on July 1.
One of Cathie Wood's Ark Invest funds bought over 460,000 shares of Quantum-Si on June 28.
